Navigation Links
Algeta Demonstrates Targeted Cancer-killing Potential of Novel,Alpha Particle Linked Antibodies in Leading Medical Journal Blood

nt, well-tolerated and convenient to use.

Algeta's lead product candidate, Alpharadin, is expected to enter Phase III clinical trials in hormone refractory prostate cancer based on positive Phase II results. Alpharadin is a novel bone-seeking therapeutic based on the alpha particle emitter radium-223 and may target skeletal metastases from multiple cancer types, as well as primary bone cancers.

Algeta is also developing other technologies for delivering alpha emitters. These include microparticles, liposomes, and methods to enhance the potency of therapeutic antibodies and other tumor-targeting molecules by linking them to the alpha particle emitter thorium-227.

The Company is headquartered in Oslo, Norway, and was founded in 1997. Algeta listed on the Oslo Stock Exchange in March 2007 (Ticker: ALGETA).

Alpharadin and Algeta are trademarks of Algeta ASA.

Forward-looking Statement

This news release contains forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on results of operations and the financial condition of Algeta. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Theses factors include, among other things, risks associated with technological development, the risk that research & development will not yield new products that achieve commercial success, the impact of competition, the ability to close viable and profitable business deals, the risk of non-approval of patents not yet granted and difficulties of obtaining relevant governmental approvals for new products

###

This content was distributed through Hugin - connecting communication professionals/with their target audience. Visit us at
'"/>





Page: 1 2 3 4

Related medicine technology :

1. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
9. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
10. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
11. Lpath Demonstrates First-in-Class AMD Results With Its Lead Drug Candidate, Sphingomab
Post Your Comments:
(Date:9/1/2015)... Sept. 1, 2015 Sargas Pharmaceutical Adherence ... and Drug Adherence m Health applications along with ... process of non face-to-face monitoring of twenty minutes ... release of our apps, doctors are now well ... with our ONCHIT certified Physician, Pharmacy and Patient ...
(Date:9/1/2015)... Within just two years after reaching a ... reached 3,000 employees worldwide. This increase is reflecting ... drug delivery market and SHL,s effective commitment, productivity ... the design and manufacturing of auto injectors and ... capabilities, a lean supply chain, strong partnerships, and ...
(Date:9/1/2015)... 2015 Egalet Corporation (Nasdaq: EGLT ... focused on discovering, developing, and commercializing innovative pain ... scientific data on SPRIX ® (ketorolac tromethamine) ... product candidate, and Egalet-002, an abuse-deterrent, extended-release, oral ... 2015 to be held September 8 to 12 ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2SHL Group Reaches Major Milestone of 3000 Employees 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
... Inc., a privately-held therapeutic device company, today announced ... with Bezwada Biomedical to develop and commercialize Bezwada,s ... Biomedical is an innovation-driven company with proprietary technology ... polyamides derived from hydrolyzable isocyanates. This technology can ...
... Aug. 31, 2011 Assured Pharmacy, Inc. (Pink Sheets: ... that provide advanced prescription services to a diverse array ... it sold in a private placement to an accredited ... an aggregate principal amount of $400,000 due December 1, ...
Cached Medicine Technology:ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical 2Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants 2Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants 3
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, Inc., a national ... medical management team as an Associate Medical Director. , WorkCare specializes in ... the U.S. and abroad. , Dr. Nelson has a diverse background. He ...
(Date:9/1/2015)... ... 01, 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, ... of the Best” firm in the U.S., as well as being ranked a Top ... in the U.S., selected exclusively on performance in specific areas of financial and operational ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Mercy Health ... has devoted the 10th of its monthly Mercy Health: Helping You Be Well videos ... one in seven men. , In a concise video on Mercy Health’s YouTube ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... ... discount cards, launched its consumer-friendly, informational video this week to coincide with back-to-school ... http://www.USAMedicalCard.com/video . , According to the CDC, elementary school children are sick ...
(Date:9/1/2015)... OHIO (PRWEB) , ... September 01, 2015 , ... Dr. ... today at JourneyLite of Cincinnati. In the last month the FDA has approved ... ReShape Duo ™. These procedures represent the first incisionless, reversible, weight loss procedures ...
Breaking Medicine News(10 mins):Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2
... the skin unleashes a complex cascade of chemistry to stem ... of Medicine in St. Louis have used evolutionary clues to ... new light on common bleeding disorders. The long tube-shaped ... von Willebrand Factor (VWF). Made in cells that form the ...
... to improve global health, alleviate hunger, raise living standards ... an important role to play. Jagdev ... and Vaccinology at Arizona State University,s Biodesign Institute has ... of chicken for villagers in rural Uganda. He reports ...
... WEDNESDAY, July 20 (HealthDay News) -- The number of surgical ... new study finds. In reviewing adverse events and close ... report in the July 15 issue of the Archives ... a greater emphasis on safety, as well as improved training ...
... in the Breast Health Center at Women & Infants ... to earn a 2011 Breast Cancer Symposium Merit Award ... of Clinical Oncology (ASCO). The award, which recognizes ... to Shannon MacLaughlan, MD, who is also affiliated with ...
... that is affected during the onset of schizophrenia and successfully ... drug currently in advanced clinical trials., The research, published ... group led by Professor Peter Giese at King,s College London, ... Schizophrenia is one of the most common serious mental health ...
... of thousands of people, injuring a muscle through an accident ... in a strange and serious complication. Their muscles start growing ... abnormal bone growth, so there was no treatment. But now, ... Perelman School of Medicine at the University of Pennsylvania shows ...
Cached Medicine News:Health News:Evolution provides clue to blood clotting 2Health News:Evolution provides clue to blood clotting 3Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 2Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 3Health News:Fewer Surgical Errors Reported at VA Medical Facilities 2Health News:Cancer drugs may help treatment of schizophrenia 2Health News:When injured muscles mistakenly grow bones 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: